BNTC icon

Benitec Biopharma

21 hedge funds and large institutions have $2.54M invested in Benitec Biopharma in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SCM
1
Suvretta Capital Management
New York
$1.8M 769,000
Vanguard Group
2
Vanguard Group
Pennsylvania
$183K 78,371
Geode Capital Management
3
Geode Capital Management
Massachusetts
$139K 59,566 +1,153 +2%
Barclays
4
Barclays
United Kingdom
$137K 58,695 +58,695 New
AI
5
Atom Investors
Texas
$87K 37,335 +37,335 New
State Street
6
State Street
Massachusetts
$50K 21,438 +438 +2%
BlackRock
7
BlackRock
New York
$46K 19,554 -945 -5%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$35K 14,932
WA
9
WealthTrust Axiom
Pennsylvania
$30K 12,950
Northern Trust
10
Northern Trust
Illinois
$28K 11,813
Group One Trading
11
Group One Trading
Illinois
$5K 2,000
TRCT
12
Tower Research Capital (TRC)
New York
$4K 1,594 +1,594 New
UBS Group
13
UBS Group
Switzerland
$1K 347 -2,759 -89%
MHR
14
Matthew Hamilton Rosenberg
$1K 381
SCM
15
Silverarc Capital Management
Massachusetts
$57 492,880 -94,619 -16%
VF
16
Virtu Financial
New York
-10,456 Closed
CCM
17
Chilton Capital Management
Texas
-66 Closed
Wells Fargo
18
Wells Fargo
California
$0 43
Rockefeller Capital Management
19
Rockefeller Capital Management
New York
$0 300
CFGS
20
Concourse Financial Group Securities
Alabama
FPS
21
Fieldpoint Private Securities
Connecticut
$0 9
Citigroup
22
Citigroup
New York
$0 12 +12 New
Morgan Stanley
23
Morgan Stanley
New York
$0 100 +100 New
Simplex Trading
24
Simplex Trading
Illinois
$0 100 +100 New